C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
OGI Canadian LP

OrganiGram Holdings

NASDAQ · OGI

Canadian LP focused on indoor-grown cannabis. Known for premium flower brands and international medical exports.

$0.94
-2.96%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
51/100 composite
Fundamentals57
Regulatory66
Market40
Editorial30
Composite · trailing 12 months

OrganiGram Holdings lands at 51 on the CIN composite, a Neutral outcome with conviction of 1/5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 66 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.

The observable inputs tell a straightforward story: reported revenue growth of -8.9 percent year over year, an operating margin of -16.4 percent, gross margin of 35.6 percent, a market cap near 136 million, a filing cadence of 2 regulator events in the trailing 90 days, a jurisdictional posture reading of 80. Every figure is auditable in the accompanying pillar table. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets OrganiGram Holdings be lined up against the global cannabis coverage universe on identical inputs, with refresh cadence tied directly to primary-source ingest.

Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 66. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
1400-145 KING ST. WEST, TORONTO, M5H 1J8
Phone
506-232-4400
CEO
James Yamanaka
CFO
Greg Guyatt
SEC CIK
1620737
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$136.1M
Enterprise value
$138.0M
Price to book
0.52
Price to sales
0.50
EV / EBITDA
34.77
Revenue (TTM)
$274.2M
Gross profit (TTM)
$97.7M
EBITDA
$3.0M
Operating margin
-16.4%
Profit margin
-9.2%
Rev growth YoY
-8.9%
Return on equity
-5.9%
Return on assets
-1.7%
EPS (TTM)
$-0.15
EPS est. current year
$0.07
Wall St. target price
$8.80
Shares outstanding
140.8M
Insider ownership
30.3%
Institutional ownership
6.5%
Beta
1.85
Full-time employees
1,120
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for OrganiGram Holdings (OGI)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for OrganiGram Holdings (OGI), a cannabis-sector equity listed on NASDAQ in the Canadian LP category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Avoid / Capital Risk. Multiple flags: deep drawdown. (0 bullish signals, 3 bearish signals.)

Bullish and bearish analyst opinions for Organigram Global Inc. (OGI)

Bullish view. Organigram Global is one of the cheapest LP names on EV/sales, and its BAT-anchored balance sheet gives it dry powder that most Canadian peers lack.

Bearish view. Bearish views focus on the crowded Canadian rec market, thin gross margins, and the lack of a US catalyst path.

Live ratings, price targets, and consensus figures for Organigram Global Inc. appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Canadian LP focused on indoor-grown cannabis. Known for premium flower brands and international medical exports.

Latest price: $0.94 (-2.96%) on NASDAQ.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for OGI are maintained by Cannabis Investor News and refreshed throughout the trading day.